Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistanceDaisuke Muraoka, Hiroshi Shiku, Tae Hayashi et al.|Journal of Clinical Investigation|2019Cited by 143
Inhibition of STAT3 by Anticancer Drug BendamustineKazunori Iwamoto, Akira Asai|PLoS ONE|2017Cited by 16
Discovery of a New STAT3 Inhibitor Acting on the Linker DomainTatsuya Koseki, Akira Asai|Biological and Pharmaceutical Bulletin|2019Cited by 13
Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell linesKeisuke Taniguchi, Akira Asai|Scientific Reports|2021Cited by 12
Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppiYusuke Okada, Akira Asai|Scientific Reports|2018Cited by 11